市場概況

The global Continuous Bioprocessing Market size is anticipated to expand from USD 133.9 百万で 2022 米ドルへ 443.1 百万までに 2029, registering a compound annual growth rate (CAGR) の 17.9% 予測期間中.

Continuous bioprocessing involves uninterrupted production of biopharmaceuticals using integrated systems, offering advantages such as scalability, cost savings, and consistent quality compared to traditional batch methods. It finds widespread application in the manufacturing of vaccines, モノクローナル抗体, and other biologics. Market growth is driven by the rising adoption of continuous processing approaches, technological advancements, increasing investments in biomanufacturing, and supportive government initiatives and policies worldwide. In addition, the growing prevalence of chronic diseases that necessitate biopharmaceutical treatment, such as cancer, is a key factor fueling demand.

しかし, stringent regulatory norms governing biopharmaceutical production and the high costs associated with continuous bioprocessing equipment and infrastructure pose challenges. The COVID-19 pandemic also disrupted research and development activities, delaying some projects in the short term.

市場セグメンテーション

市場はさまざまな要因に基づいて分割されます, including Product, 応用, エンドユーザー, and Geography

製品ごとのセグメンテーション
Filtration Systems and Consumables
Chromatography Systems and Consumables
Bioreactors
Sterilizers
Centrifuges
その他

Segmentation by Application
コマーシャル
Research and Development

エンドユーザーごとのセグメンテーション
Pharmaceutical and Biotechnology Companies
CDMOs and CROs
Academic and Research Institutes

地理によるセグメンテーション
北米 – アメリカ, カナダ, メキシコ
ヨーロッパ – イギリス, ドイツ, フランス, イタリア, スペイン, およびその他のヨーロッパ
アジア太平洋地域 – 中国, 日本, インド, オーストラリア, 韓国, およびその他のアジア太平洋地域
ラテンアメリカ – ブラジル, アルゼンチン, およびその他のラテンアメリカ諸国
中東とアフリカ – GCC, 南アフリカ, およびその他の中東およびアフリカ

The research and development segment of the continuous bioprocessing market is projected to grow significantly due to increasing R&D expenditure, growing demand for biopharmaceuticals, new facility establishments, and technological advancements. Transcenta’s breakthrough in March 2021, achieving high productivity in continuous perfusion cell culture, exemplifies the sector’s progress. Collaborative efforts, like the USP and Phlow Corp. partnership, aim to promote wider adoption of continuous manufacturing. The establishment of dedicated biomanufacturing facilities for research and development activities will further drive market growth. The research and development segment will play a crucial role in overall market expansion.

The North American continuous processing market is driven by factors such as the burden of chronic diseases, product launches, strategic initiatives by market players, facility establishments, and technological advancements. The United States is expected to hold a significant market share, driven by the demand for biopharmaceuticals. A study suggests the economic attractiveness of continuous manufacturing in the US for oral solid dosage pharmaceuticals. These factors contribute to the anticipated growth of the continuous bioprocessing market.

競争環境

The continuous bioprocessing market is competitive, with a few major players holding significant market share. Notable companies include 3M Company, Bionet Servicios Tecnicos S.L., バイオ・ラッド・ラボラトリーズ株式会社, ダナハーコーポレーション, Dover Corporation (Colder Products Company), Eppendorf SE, Fujifilm Corporation, Getinge AB, メルクKGaA, Repligen Corporation, Sartorius AG, and Thermo Fisher Scientific Inc.

最近の業界の発展

CellulaREvolution raised GBP 1.75 million in February 2022 from notable investors, led by Happiness Capital. The funding will support their research and development efforts and strengthen their commercial team for the upcoming launch of their continuous cell culture technology.

In January 2022, WuXi Biologics invested EUR 325 million to enhance their biomanufacturing capabilities. The investment will be used to establish a state-of-the-art facility for continuous bioprocessing, improving efficiency and productivity.

このレポートを購入する理由?

Get a detailed picture of the Global Continuous Bioprocessing Market
Identify segments/areas to invest in over the forecast period in the Global Continuous Bioprocessing Market
競争環境を理解する, 市場の主要企業
Excel 形式でのシナリオ全体の分析を容易にするための市場予測
3ヶ月間の戦略コンサルティングとリサーチサポート
シングルユーザーライセンスに提供される印刷認証